Skip to main content

Loading market data...

BSX

Boston Scientific Corporation

NYSE • United states

$45.57

+$0.52

(+1.15%)

Source: Yahoo Finance · Quote time Oct 20, 2026 19:47 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Boston Scientific Corporation (BSX)

Unavailable

Quotes may be delayed

$66.04B

Market Cap

12,810,265

Volume

18.0

P/E Ratio

Unavailable

Div Yield

Boston Scientific Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

7 Oct 2026

Boston Scientific Corporation reported A director or senior management change or compensation event

Boston Scientific Corporation filed an 8-K covering a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.

23 Sep 2026

Boston Scientific Corporation reported A director or senior management change or compensation event

Boston Scientific Corporation filed an 8-K covering a director or senior management change or compensation event.

8 Sep 2026

Boston Scientific Corporation reported A material cybersecurity incident

Boston Scientific Corporation filed an 8-K covering a material cybersecurity incident.

26 Aug 2026

Boston Scientific Corporation reported Another company event

Boston Scientific Corporation filed an 8-K covering another company event.

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Boston Scientific Corporation.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$539.00M

Total assets (USD)$45.22B

Shareholders' equity (USD)$24.93B

Long-term debt (USD)$4.81B

Debt due within a year (USD)$1.71B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$5.44B	$1.18B	$905.00M	$0.61	10-Q · 3 Aug 2026
Q1 2026	$5.20B	$1.10B	$1.34B	$0.90	10-Q · 1 May 2026
Q4 2025	$5.29B	$825.00M	$670.00M	Unavailable	10-K · 17 Feb 2026
Q3 2025	$5.07B	$1.05B	$755.00M	$0.51	10-Q · 3 Nov 2025
Q2 2025	$5.06B	$819.00M	$795.00M	$0.53	10-Q · 1 Aug 2025
Q1 2025	$4.66B	$921.00M	$672.00M	$0.45	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $57.14

25.4% upside potential

📈

Strong Buy

Unavailable

👍

Buy

18

⏸️

Hold

4

📉

Sell

0

22 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 19:47 UTC Targets range 48.00–70.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

2

Sep 2026

O'Connor Padraig Andrew

EVP, Global Operations

Option exercise

Unavailable per share

1,171 shares

2

Sep 2026

O'Connor Padraig Andrew

EVP, Global Operations

Tax withholding

$48.37 per share

567 shares

25

Aug 2026

Morano Susan E

Director

Open-market purchase

$49.22 per share

2,040 shares

11

Aug 2026

Woodworth Emily

SVP, Global Controller and CAO

Discretionary transaction

$51.19 per share

2,930 shares

10

Aug 2026

Monson Jonathan

EVP and CFO

Discretionary transaction

$50.46 per share

9,908 shares

5

Aug 2026

Habiger David C

Director

Open-market purchase

$47.59 per share

2,100 shares

4

Aug 2026

Habiger David C

Director

Open-market purchase

$48.59 per share

140 shares

3

Aug 2026

Habiger David C

Director

Open-market purchase

$48.07 per share

1,042 shares

3

Aug 2026

Mahoney Michael F

Director, Chairman, President & CEO

Open-market purchase

$48.33 per share

186,240 shares

3

Aug 2026

Mahoney Michael F

Director, Chairman, President & CEO

Discretionary transaction

$48.43 per share

22,119 shares

Top Shareholders

Vanguard Group Inc

139,685,997 shares

1.039% change

12/31/2025

Blackrock, Inc.

129,680,916 shares

-1.624% change

6/30/2026

Vanguard Capital Management Llc

97,087,553 shares

0.701% change

6/30/2026

State Street Corp

70,111,196 shares

3.125% change

6/30/2026

Primecap Management Co/Ca/

50,520,914 shares

55.307% change

6/30/2026

Fmr Llc

45,702,845 shares

-38.428% change

6/30/2026

Geode Capital Management, Llc

33,440,102 shares

0.464% change

6/30/2026

Vanguard Portfolio Management Llc

29,792,794 shares

-0.011% change

6/30/2026

D. E. Shaw & Co., Inc.

25,457,409 shares

4.71% change

6/30/2026

Massachusetts Financial Services Co /Ma/

24,859,191 shares

126.063% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 19:47 UTC· 1 day ago

Research coverage and investment tools

Boston Scientific Corporation (BSX) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$45.57 on 20 Oct 2026. That is 7% of the way from its 52-week low of US$41.39 to its 52-week high of US$105.65. Its market capitalisation was US$66.04 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$5.44B	$1.18B	$905.00M	$0.61	70.7%	21.6%	$1.28B	10-Q · 3 Aug 2026 (opens in a new tab)
Q1 2026	$5.20B	$1.10B	$1.34B	$0.90	69.5%	21.2%	$171.00M	10-Q · 1 May 2026 (opens in a new tab)
Q4 2025	$5.29B	$825.00M	$670.00M	Unavailable	69.6%	15.6%	$1.01B	10-K · 17 Feb 2026 (opens in a new tab)
Q3 2025	$5.07B	$1.05B	$755.00M	$0.51	69.9%	20.7%	$1.16B	10-Q · 3 Nov 2025 (opens in a new tab)
Q2 2025	$5.06B	$819.00M	$795.00M	$0.53	67.7%	16.2%	$1.13B	10-Q · 1 Aug 2025 (opens in a new tab)
Q1 2025	$4.66B	$921.00M	$672.00M	$0.45	68.8%	19.8%	$354.00M	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $539.00M
Total assets: $45.22B
Shareholders' equity: $24.93B
Long-term debt: $4.81B
Debt due within a year: $1.71B

8-K · 7 Oct 2026 · Management change

Boston Scientific Corporation reported A director or senior management change or compensation event (opens in a new tab)

Boston Scientific Corporation filed an 8-K covering a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.
8-K · 23 Sep 2026 · Management change

Boston Scientific Corporation reported A director or senior management change or compensation event (opens in a new tab)

Boston Scientific Corporation filed an 8-K covering a director or senior management change or compensation event.
8-K · 8 Sep 2026 · Cybersecurity incident

Boston Scientific Corporation reported A material cybersecurity incident (opens in a new tab)

Boston Scientific Corporation filed an 8-K covering a material cybersecurity incident.
8-K · 26 Aug 2026

Boston Scientific Corporation reported Another company event (opens in a new tab)

Boston Scientific Corporation filed an 8-K covering another company event.
SCHEDULE 13G/A · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Boston Scientific Corporation.

Insider	Date	Transaction	Shares	Average price	Filing
O'Connor Padraig Andrew EVP, Global Operations	2 Sep 2026	Option exercise (M)	+1,171	—	Form 4 (opens in a new tab)
O'Connor Padraig Andrew EVP, Global Operations	2 Sep 2026	Tax withholding (F)	−567	$48.37	Form 4 (opens in a new tab)
Morano Susan E Director	25 Aug 2026	Open-market purchase (P)	+2,040	$49.22	Form 4 (opens in a new tab)
Woodworth Emily SVP, Global Controller and CAO	11 Aug 2026	Discretionary transaction (I)	+2,930	$51.19	Form 4 (opens in a new tab)
Monson Jonathan EVP and CFO	10 Aug 2026	Discretionary transaction (I)	+9,908	$50.46	Form 4 (opens in a new tab)
Habiger David C Director	5 Aug 2026	Open-market purchase (P)	+2,100	$47.59	Form 4 (opens in a new tab)
Habiger David C Director	4 Aug 2026	Open-market purchase (P)	+140	$48.59	Form 4 (opens in a new tab)
Habiger David C Director	3 Aug 2026	Open-market purchase (P)	+1,042	$48.07	Form 4 (opens in a new tab)
Mahoney Michael F Director, Chairman, President & CEO	3 Aug 2026	Open-market purchase (P)	+186,240	$48.33	Form 4 (opens in a new tab)
Mahoney Michael F Director, Chairman, President & CEO	3 Aug 2026	Discretionary transaction (I)	+22,119	$48.43	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	139,685,997	1.039%
Blackrock, Inc.	6/30/2026	129,680,916	-1.624%
Vanguard Capital Management Llc	6/30/2026	97,087,553	0.701%
State Street Corp	6/30/2026	70,111,196	3.125%
Primecap Management Co/Ca/	6/30/2026	50,520,914	55.307%
Fmr Llc	6/30/2026	45,702,845	-38.428%
Geode Capital Management, Llc	6/30/2026	33,440,102	0.464%
Vanguard Portfolio Management Llc	6/30/2026	29,792,794	-0.011%
D. E. Shaw & Co., Inc.	6/30/2026	25,457,409	4.71%
Massachusetts Financial Services Co /Ma/	6/30/2026	24,859,191	126.063%

Previous close: 45.05 USD
Day range: 45.16 – 46.05 USD
52-week range: 41.39 – 105.65 USD
Volume: 12,810,265
Market cap: $66.04B
Average volume: 8,684,835
P/E ratio: 18.0
EPS (FY 2025, diluted): 1.94 USD
Shares outstanding: 1.45B
Beta (5Y monthly): 0.58

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 19:47 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:07 UTC· 26 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for BSX yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.